Your browser doesn't support javascript.
loading
Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain.
Barrachina-Martinez, Isabel; Vivas-Consuelo, David; Reyes-Santias, Francisco.
Affiliation
  • Barrachina-Martinez I; INECO, Universitat Politècnica De Valencia, Spain.
  • Vivas-Consuelo D; INECO, Universitat Politècnica De Valencia, Spain.
  • Reyes-Santias F; Departamento De Organización De Empresas Y Marketing, Universidad De Vigo, Facultad De Ciencias Empresarias E Turismo, Ourense, Spain.
Expert Rev Pharmacoecon Outcomes Res ; 21(5): 1081-1090, 2021 Oct.
Article in En | MEDLINE | ID: mdl-33074031
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidinones / Epilepsy / Anticonvulsants Type of study: Health_economic_evaluation Aspects: Patient_preference Limits: Humans Country/Region as subject: Europa Language: En Journal: Expert Rev Pharmacoecon Outcomes Res Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: España Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidinones / Epilepsy / Anticonvulsants Type of study: Health_economic_evaluation Aspects: Patient_preference Limits: Humans Country/Region as subject: Europa Language: En Journal: Expert Rev Pharmacoecon Outcomes Res Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: España Country of publication: Reino Unido